12 October is World Arthritis Day, highlighting a global health concern affecting millions worldwide. Arthritis can significantly impact daily life, causing difficulties with activities and leading to mental health challenges.

Many types of arthritis are inflammatory, impacting not only joints but also internal organs. Common inflammatory arthritis conditions include rheumatoid arthritis (RA), axial spondyloarthritis (axSpA), and psoriatic arthritis (PsA). Early intervention is crucial for managing inflammation and preventing further damage.

Together, we can work towards better understanding, treatment, and support for these challenging conditions. While focusing on endometriosis, Gesynta Pharma recognizes the potential for potent and selective mPGES-1 inhibitors also in providing better treatments for inflammatory arthritis patients.